Latest news with #Limerick-headquartered

Irish Examiner

Limerick's AMCS acquires UK and Australian firms

Jimmy Martin's AMCS has continued its expansion with the acquisition of companies in the UK and Australia. The Limerick-headquartered software firm has made more than 20 acquisitions in recent years, as it expands its presence in the waste management and recycling sector. AMCS said it has acquired London-based Selected Interventions, a software provider specialised in municipal resource management solutions with customers across residential, commercial, industrial, and municipal waste collection services. The company's flagship ECHO program supports residential waste services for approximately 19m residents worldwide. 'Selected Interventions' and the ECHO solution are a perfect complement to AMCS and our award-winning Performance Sustainability Suite,' said Jimmy Martin, co-founder and CEO of AMCS. 'This acquisition enables us to deepen our relationships with our existing shared customers and expand our reach into new markets." AMCS also announced the acquisition of Mandalay Technologies, an Australia-headquartered provider of weighbridge and data management solutions for the waste and resource recovery industry. "Over one-third of Australia's waste facilities rely on Mandalay Technologies' cloud-based weighbridge and data management systems for their operations,' said Mr Martin. Together, Mandalay and AMCS can provide our customers in Australia with enhanced operational visibility, optimised workflows, and leverage AI-driven analytics to improve efficiency, material quality, and sustainability outcomes. Financial details of both acquisitions were not disclosed. AMCS has 1,300 employees, with 4,000 customers across 80 countries. The company has offices in North America, Europe, and Australia in addition to its Limerick headquarters. Last year, private equity firm EQT acquired a majority stake in AMCS for an undisclosed amount. Following the acquisition, the co-founder, management, and others including existing majority investor Insight Partners, as well as Clearlake Capital, Highland Europe and the Ireland Strategic Investment Fund are expected to retain minority stakes. Read More Clonmel-based Shorla Oncology to increase revenues significantly